(Q36657607)

English

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

scientific article published on 23 June 2015

Statements

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice (English)
23 June 2015

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit